Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement

Detalhes bibliográficos
Autor(a) principal: Ribeiro,S.L.E.
Data de Publicação: 2008
Outros Autores: Pereira,H.L.A., Silva,N.P., Neves,R.M.S., Sato,E.I.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Medical and Biological Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001100010
Resumo: The objective of the present research was to evaluate the usefulness of anti-cyclic citrullinated peptide (anti-CCP) antibodies and the IgM rheumatoid factor (IgM RF) test for the differential diagnosis of leprosy with articular involvement and rheumatoid arthritis (RA). Anti-CCP antibodies and IgM RF were measured in the sera of 158 leprosy patients (76 with and 82 without articular involvement), 69 RA patients and 89 healthy controls. Leprosy diagnosis was performed according to Ridley and Jopling classification criteria and clinical and demographic characteristics of leprosy patients were collected by a standard questionnaire. Leprosy patients with any concomitant rheumatic disease were excluded. Serum samples were obtained from all participants and frozen at _20°C. Measurement of anti-CCP antibodies and IgM RF were performed by ELISA, using a commercial second-generation kit, and the latex agglutination test, respectively. Anti-CCP antibodies and IgM RF were detected in low frequencies (2.6 and 1.3%, respectively) in leprosy patients and were not associated with articular involvement. Among healthy individuals both anti-CCP antibodies and IgM RF were each detected in 3.4% of the subjects. In contrast, in the RA group, anti-CCP antibodies were present in 81.2% and IgM RF in 62.3%. In the present study, both anti-CCP antibodies and IgM RF showed good positive predictive value for RA, helping to discriminate between RA and leprosy patients with articular involvement. However, anti-CCP antibodies were more specific for RA diagnosis in the population under study.
id ABDC-1_5a87f1f260c169564a1773ddc4602f1c
oai_identifier_str oai:scielo:S0100-879X2008001100010
network_acronym_str ABDC-1
network_name_str Brazilian Journal of Medical and Biological Research
repository_id_str
spelling Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvementLeprosyRheumatoid arthritisAnti-cyclic citrullinated peptide antibodiesRheumatoid factorThe objective of the present research was to evaluate the usefulness of anti-cyclic citrullinated peptide (anti-CCP) antibodies and the IgM rheumatoid factor (IgM RF) test for the differential diagnosis of leprosy with articular involvement and rheumatoid arthritis (RA). Anti-CCP antibodies and IgM RF were measured in the sera of 158 leprosy patients (76 with and 82 without articular involvement), 69 RA patients and 89 healthy controls. Leprosy diagnosis was performed according to Ridley and Jopling classification criteria and clinical and demographic characteristics of leprosy patients were collected by a standard questionnaire. Leprosy patients with any concomitant rheumatic disease were excluded. Serum samples were obtained from all participants and frozen at _20°C. Measurement of anti-CCP antibodies and IgM RF were performed by ELISA, using a commercial second-generation kit, and the latex agglutination test, respectively. Anti-CCP antibodies and IgM RF were detected in low frequencies (2.6 and 1.3%, respectively) in leprosy patients and were not associated with articular involvement. Among healthy individuals both anti-CCP antibodies and IgM RF were each detected in 3.4% of the subjects. In contrast, in the RA group, anti-CCP antibodies were present in 81.2% and IgM RF in 62.3%. In the present study, both anti-CCP antibodies and IgM RF showed good positive predictive value for RA, helping to discriminate between RA and leprosy patients with articular involvement. However, anti-CCP antibodies were more specific for RA diagnosis in the population under study.Associação Brasileira de Divulgação Científica2008-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001100010Brazilian Journal of Medical and Biological Research v.41 n.11 2008reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/S0100-879X2008001100010info:eu-repo/semantics/openAccessRibeiro,S.L.E.Pereira,H.L.A.Silva,N.P.Neves,R.M.S.Sato,E.I.eng2008-12-15T00:00:00Zoai:scielo:S0100-879X2008001100010Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2008-12-15T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false
dc.title.none.fl_str_mv Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
title Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
spellingShingle Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
Ribeiro,S.L.E.
Leprosy
Rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies
Rheumatoid factor
title_short Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
title_full Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
title_fullStr Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
title_full_unstemmed Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
title_sort Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
author Ribeiro,S.L.E.
author_facet Ribeiro,S.L.E.
Pereira,H.L.A.
Silva,N.P.
Neves,R.M.S.
Sato,E.I.
author_role author
author2 Pereira,H.L.A.
Silva,N.P.
Neves,R.M.S.
Sato,E.I.
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Ribeiro,S.L.E.
Pereira,H.L.A.
Silva,N.P.
Neves,R.M.S.
Sato,E.I.
dc.subject.por.fl_str_mv Leprosy
Rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies
Rheumatoid factor
topic Leprosy
Rheumatoid arthritis
Anti-cyclic citrullinated peptide antibodies
Rheumatoid factor
description The objective of the present research was to evaluate the usefulness of anti-cyclic citrullinated peptide (anti-CCP) antibodies and the IgM rheumatoid factor (IgM RF) test for the differential diagnosis of leprosy with articular involvement and rheumatoid arthritis (RA). Anti-CCP antibodies and IgM RF were measured in the sera of 158 leprosy patients (76 with and 82 without articular involvement), 69 RA patients and 89 healthy controls. Leprosy diagnosis was performed according to Ridley and Jopling classification criteria and clinical and demographic characteristics of leprosy patients were collected by a standard questionnaire. Leprosy patients with any concomitant rheumatic disease were excluded. Serum samples were obtained from all participants and frozen at _20°C. Measurement of anti-CCP antibodies and IgM RF were performed by ELISA, using a commercial second-generation kit, and the latex agglutination test, respectively. Anti-CCP antibodies and IgM RF were detected in low frequencies (2.6 and 1.3%, respectively) in leprosy patients and were not associated with articular involvement. Among healthy individuals both anti-CCP antibodies and IgM RF were each detected in 3.4% of the subjects. In contrast, in the RA group, anti-CCP antibodies were present in 81.2% and IgM RF in 62.3%. In the present study, both anti-CCP antibodies and IgM RF showed good positive predictive value for RA, helping to discriminate between RA and leprosy patients with articular involvement. However, anti-CCP antibodies were more specific for RA diagnosis in the population under study.
publishDate 2008
dc.date.none.fl_str_mv 2008-11-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001100010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008001100010
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0100-879X2008001100010
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
publisher.none.fl_str_mv Associação Brasileira de Divulgação Científica
dc.source.none.fl_str_mv Brazilian Journal of Medical and Biological Research v.41 n.11 2008
reponame:Brazilian Journal of Medical and Biological Research
instname:Associação Brasileira de Divulgação Científica (ABDC)
instacron:ABDC
instname_str Associação Brasileira de Divulgação Científica (ABDC)
instacron_str ABDC
institution ABDC
reponame_str Brazilian Journal of Medical and Biological Research
collection Brazilian Journal of Medical and Biological Research
repository.name.fl_str_mv Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)
repository.mail.fl_str_mv bjournal@terra.com.br||bjournal@terra.com.br
_version_ 1754302936809209856